Efficacy and Safety of Sorafenib in New-Onset Type 1 Diabetes Mellitus

NCT06227221 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes

Interventions

DRUG: Sorafenib
DRUG: Placebo

Sponsor

Second Xiangya Hospital of Central South University